ODYSSEY THERAPEUTICS
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines.
ODYSSEY THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.odysseytx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
218 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Clade Therapeutics
Clade Therapeutics discovers and delivers next-generation cell medicines to improve the lives of patients.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
PijnZorg
PijnZorg provides its clients with treatment for inflammatory pain.
Resilience
Resilience provides treatment for cancer.
Bloomwell Group
Bloomwell Group provides easy access to natural based medicine.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
ValenzaBio
ValenzaBio is developing safe and effective treatment options for patients with autoimmune and inflammatory diseases.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-13 | Rahko | Rahko acquired by Odyssey Therapeutics | N/A |
Investors List
HBM Partners
HBM Partners investment in Series B - Odyssey Therapeutics
Woodline Partners
Woodline Partners investment in Series A - Odyssey Therapeutics
SR One
SR One investment in Series A - Odyssey Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Odyssey Therapeutics
Creacion Ventures
Creacion Ventures investment in Series A - Odyssey Therapeutics
Colt Ventures
Colt Ventures investment in Series A - Odyssey Therapeutics
Foresite Capital
Foresite Capital investment in Series A - Odyssey Therapeutics
OrbiMed
OrbiMed investment in Series A - Odyssey Therapeutics
Logos Capital
Logos Capital investment in Series A - Odyssey Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-24 | Odyssey Therapeutics Appoints Darryl Patrick, D.V.M., Ph.D., as Executive Vice President of Non-Clinical Development |
Official Site Inspections
http://www.odysseytx.com Semrush global rank: 4.26 M Semrush visits lastest month: 2.73 K
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Odyssey Therapeutics"
Careers at Odyssey Therapeutics
Any employment-related communications that are not from @odysseytx.com or @hibob.com should be treated as fraudulent. Our hiring managers and external recruiting firms will not ask for sensitive personal information, money, or …See details»
Odyssey Therapeutics - Crunchbase Company Profile
Odyssey Therapeutics may be growing as it has recently completed a significant Series C financing round, securing $101 million in funding. This capital …See details»
Odyssey Therapeutics | LinkedIn
“Odyssey’s accomplished team of scientists and executives with numerous prior successes in discovery, development and commercialization has made tremendous progress in only two years.See details»
Odyssey Therapeutics - Overview, News & Similar companies
Dec 31, 2023 View Odyssey Therapeutics (www.odysseytx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Odyssey Therapeutics Inc., Frankfurt am Main (DE)
Dec 7, 2023 https://www.odysseytx.com Odyssey Therapeutics is a biotechnology company focused on discovering, developing and commercializing the next generation of …See details»
Odyssey Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
For more information, please visit odysseytx.com and follow Odyssey Therapeutics on X (formerly Twitter) and LinkedIn. ... The statistics for drugs in the Pipeline is the current organization and …See details»
Odyssey Therapeutics and Terray Therapeutics Enter Strategic ...
Oct 28, 2024 BOSTON and LOS ANGELES, October 28, 2024 — Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for …See details»
Odyssey Therapeutics Expands Management Team with Key …
Nov 9, 2022 Jeff Hermes, Ph.D., former Kallyope, Roche, and Merck R&D leader, joins as Executive Vice President of Enabling Sciences . Natalie Dales, Ph.D., promoted to Chief of …See details»
Investors News - odysseytx.com
Oct 2, 2024 Odyssey’s mission is to create extraordinary leaps in patient outcomes and change the standard of care for those living with serious inflammatory diseases. For more information, …See details»
Odyssey Therapeutics: Contact Details and Business Profile
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly …See details»
Odyssey Therapeutics Expands Management Team with Key …
Boston, Mass., November 9, 2022 -- Odyssey Therapeutics, Inc., a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today …See details»
Odyssey Therapeutics Named to 2022 Endpoints 11 - PR Newswire
Sep 22, 2022 Odyssey Therapeutics is a biotechnology company dedicated to discovering, developing and commercializing immunomodulators and oncology medicines that aim to transform drug discovery to accelerate ...See details»
Odyssey Therapeutics - PitchBook
Odyssey Therapeutics General Information Description. Operator of a biotechnology company intended to develop immunomodulators and oncology drugs. The company aims to advance the drug discovery space with its …See details»
Odyssey Therapeutics Announces Strategic Collaboration to …
BOSTON, April 04, 2024--Odyssey Therapeutics, Inc., a biotechnology company pioneering next-generation precision medicines, announced today it has entered into a strategic research collaboration ...See details»
Odyssey Therapeutics - workinbiotech.com
Odyssey Therapeutics is creating next-generation precision medicines to treat inflammatory diseases. Precision medicine provides the opportunity to develop drugs that give patients …See details»
Odyssey Therapeutics Stock - Notice
Nov 30, 2024 odysseytx.com. Last round-Market Cap-Premium-Total Funding. Days Since Funding. 403. Coverage Ratio-Health & Wellness. Oncology. Drug Discovery. Biopharma. …See details»
Odyssey Therapeutics - VentureRadar
Website: https://odysseytx.com. Develops innovative treatments for inflammatory diseases and cancer, integrating biology with technology to create transformative, patient-focused …See details»
Odyssey Therapeutics: Our Science
At Odyssey, we’re seeking to address the fundamental limitations of current autoimmune and inflammatory disease treatments. With our deep expertise in immunology and drug discovery, …See details»
Odyssey Therapeutics - Company Profile & Staff Directory
*****@odysseytx.com. View the complete 2024 Odyssey Therapeutics Employee List. Search Odyssey Therapeutics Staff Directory. Find accurate personal emails, work emails and phone …See details»